Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Roepman

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Bioanalysis|November 19, 2010
The future of diagnostic gene-expression microarrays: bridging the gap between bench and bedsidePaul Roepman
Cell Cycle (Georgetown, Tex.)|April 23, 2005
Tumor profiling turmoilPaul Roepman, Frank C P Holstege
Breast Cancer Research and Treatment|April 6, 2011
Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogsErnst-Jan Geutjes, Sun Tian, Paul Roepman, et al.
Plos One|March 3, 2012
A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patientsTimothy J Molloy, Paul Roepman, Bjørn Naume, et al.
Bioinformatics (Oxford, England)|May 11, 2021
VIRUSBreakend: Viral Integration Recognition Using Single BreakendsDaniel L Cameron, Nina Jacobs, Paul Roepman, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 12, 2023
[Whole genome sequencing to find the primary tumour in cancer of unknown primary origin]J J M van der Hoeven, Kim Monkhorst, A J van de Wouw, et al.
Cancer Research|February 21, 2006
Multiple robust signatures for detecting lymph node metastasis in head and neck cancerPaul Roepman, Patrick Kemmeren, Lodewijk F A Wessels, et al.
Biomarker Insights|December 15, 2010
Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancerSun Tian, Paul Roepman, Laura J Van't Veer, et al.
BMC Medical Genomics|August 14, 2009
A gene expression profile for detection of sufficient tumour cells in breast tumour tissue: microarray diagnosis eligibilityPaul Roepman, Arenda Schuurman, Leonie J M J Delahaye, et al.
Cancers|August 25, 2019
Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell CancerMehtap Derya Aydemirli, Willem Corver, Ruben Beuk, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Bioanalysis|November 19, 2010
The future of diagnostic gene-expression microarrays: bridging the gap between bench and bedsidePaul Roepman
Cell Cycle (Georgetown, Tex.)|April 23, 2005
Tumor profiling turmoilPaul Roepman, Frank C P Holstege
Breast Cancer Research and Treatment|April 6, 2011
Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogsErnst-Jan Geutjes, Sun Tian, Paul Roepman, et al.
Plos One|March 3, 2012
A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patientsTimothy J Molloy, Paul Roepman, Bjørn Naume, et al.
Bioinformatics (Oxford, England)|May 11, 2021
VIRUSBreakend: Viral Integration Recognition Using Single BreakendsDaniel L Cameron, Nina Jacobs, Paul Roepman, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 12, 2023
[Whole genome sequencing to find the primary tumour in cancer of unknown primary origin]J J M van der Hoeven, Kim Monkhorst, A J van de Wouw, et al.
Cancer Research|February 21, 2006
Multiple robust signatures for detecting lymph node metastasis in head and neck cancerPaul Roepman, Patrick Kemmeren, Lodewijk F A Wessels, et al.
Biomarker Insights|December 15, 2010
Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancerSun Tian, Paul Roepman, Laura J Van't Veer, et al.
BMC Medical Genomics|August 14, 2009
A gene expression profile for detection of sufficient tumour cells in breast tumour tissue: microarray diagnosis eligibilityPaul Roepman, Arenda Schuurman, Leonie J M J Delahaye, et al.
Cancers|August 25, 2019
Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell CancerMehtap Derya Aydemirli, Willem Corver, Ruben Beuk, et al.
Pageof 7